Description
FOXO4-DRI is a synthetic peptide engineered to disrupt the interaction between the FOXO4 transcription factor and p53 within senescent cells, studied in cellular ageing (senescence) research.
In laboratory research, FOXO4-DRI is examined for its proposed capacity to selectively interfere with FOXO4-p53 binding, which in senescent cells is thought to sequester p53 in the nucleus and prevent apoptosis, allowing senescent cells to persist.
Researchers studying FOXO4-DRI focus on its use as a tool for investigating senolytic mechanisms, i.e., pathways involved in selectively triggering apoptosis in senescent cells while sparing healthy, non-senescent cells in experimental models.
Its targeted mechanism has made FOXO4-DRI a frequently cited compound in the growing field of cellular senescence and ageing biology research.
FOXO4-DRI is supplied strictly for laboratory research into cellular senescence, transcription factor biology, and ageing-related signaling pathways.
Reviews
There are no reviews yet.